Bioextrax AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.56	3.93	17.27	13.4	27.53	8.98
Cash & Short-Term Investments	11.56	3.93	17.27	13.4	27.53	8.98
Cash Growth	-4.73%	-77.23%	28.87%	-51.33%	206.69%	337.54%
Accounts Receivable	-	0.03	0	-	0.03	0.12
Other Receivables	0.55	0.53	0.49	0.54	1.18	0.58
Total Trade Receivables	0.55	0.56	0.49	0.54	1.21	0.7
Other Current Assets	1.26	1.06	1.44	0.82	1.66	1.74
Total Current Assets	13.37	5.54	19.2	14.76	30.4	11.42
Net Property, Plant & Equipment	5.64	5.84	6.82	7.76	7.49	1.22
Other Long-Term Assets	-	13.34	2.98	-	0.07	0
Total Assets	19	24.73	29	22.52	37.92	12.64
Accounts Payable	0.36	1.18	1.53	1.33	3.56	2.22
Accrued Expenses	1.28	1.6	1.04	-0.02	1.99	2.61
Other Current Liabilities	0.47	0.73	0.37	0.67	0.61	0.31
Total Current Liabilities	2.11	3.51	2.94	1.98	6.15	5.14
Total Liabilities	2.11	3.51	2.94	1.98	6.15	5.14
Common Stock	2.4	2.4	2.02	1.47	1.28	0.74
Additional Paid-in Capital	-	12.14	22.32	9.86	41.73	15.96
Retained Earnings	14.49	6.68	1.73	9.21	-11.24	-9.2
Shareholders' Equity	16.89	21.22	26.06	20.54	31.77	7.5
Total Liabilities & Equity	19	24.73	29	22.52	37.92	12.64
Net Cash (Debt)	11.56	3.93	17.27	13.4	27.53	8.98
Net Cash Growth	194.10%	-77.23%	28.87%	-51.33%	206.69%	337.54%
Net Cash Per Share	0.28	0.10	0.52	0.51	1.63	0.67
Book Value	16.89	21.22	26.06	20.54	31.77	7.5
Book Value Per Share	0.41	0.54	0.78	0.77	1.88	0.56
Tangible Book Value	16.89	21.22	26.06	20.54	31.77	7.5
Tangible Book Value Per Share	0.41	0.54	0.78	0.77	1.88	0.56